Dexamethasone Versus Magnesium Sulphate as an Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block for Postoperative Analgesia in Elective Caesarean Section Under Spinal Anesthesia
The Efficacy of Dexamethasone Versus Magnesium Sulphate as an Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block for Postoperative Analgesia in Elective Caesarean Section Under Spinal Anesthesia: A Randomized Controlled Trial.
Cairo University
150 participants
Dec 1, 2023
INTERVENTIONAL
Conditions
Summary
This study aims to compare the efficacy of adding dexamethasone and magnesium sulfate as an adjuvant to bupivacaine in bilateral erector spinae block in postoperative pain control in patients undergoing caesarean section under spinal anesthesia.
Eligibility
Inclusion Criteria4
- Age from 18 to 35 years.
- Full-term, singleton, pregnant women.
- American Society of Anesthesiologists (ASA) physical status II.
- Scheduled for elective cesarean delivery under spinal anesthesia.
Exclusion Criteria9
- Refusal of the patient.
- Emergency caesarean sections.
- Patients having chronic diseases as asthma, cardiovascular disorders (Significant arrhythmias, Severe Valvular diseases, congenital heart diseases, ischemic heart disease, cardiomyopathy, deep venous thrombosis ,and pulmonary embolism)
- Renal impairment (Creatinine level ≥ 2mg/dl, urea ≥ 25mg/dL), liver impairment \[Alanine aminotransferase (ALT) \< 45 U/L, Aspartate aminotransferase (AST) \< 45 U/L\].
- Allergy to the drug enrolled in the study.
- Body mass index (BMI) ≥ 35 kg/m2.
- Hypertensive disorders of pregnancy.
- Contraindication to spinal anesthesia, such as coagulopathy \[platelet count \<150.000, international normalized ratio (INR) \> 1.2\], or local infection.
- Requirement for conversion to general anesthesia after spinal anesthesia will also be excluded.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive 20 ml of 0.25% isobaric bupivacaine.
Patients will receive 20 ml of (0.25% isobaric bupivacaine and 4mg of dexamethasone).
Patients will receive 20 ml of (0.25% isobaric bupivacaine and 200mg of magnesium sulphate).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07139522